Literature DB >> 5706751

Experimental toxocariasis. II. Toxocara canis in the mouse as a system for testing compounds of potential anthelmintic acitivity.

C H Burren.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5706751     DOI: 10.1007/bf00259725

Source DB:  PubMed          Journal:  Z Parasitenkd        ISSN: 0044-3255


× No keyword cloud information.
  12 in total

1.  EFFECT OF THIABENDAZOLE UPON THE ENTERAL AND PARENTERAL PHASES OF TRICHINOSIS IN MICE.

Authors:  W C CAMPBELL; A C CUCKLER
Journal:  J Parasitol       Date:  1964-08       Impact factor: 1.276

2.  Thiabendazole treatment of the invasive phase of experimental trichinosis in swine.

Authors:  W C CAMPBELL; A C CUCKLER
Journal:  Ann Trop Med Parasitol       Date:  1962-12

3.  INFECTION WITH ANIMAL HELMINTHS.

Authors:  A W WOODRUFF; C K THACKER
Journal:  Br Med J       Date:  1964-04-18

4.  Standardization of techniques for infecting mice with Toxocara canis and observations on the normal migration routes of the larvae.

Authors:  T OSHIMA
Journal:  J Parasitol       Date:  1961-08       Impact factor: 1.276

5.  Observations on the development of Toxocara canis (Werner, 1782) in the dog.

Authors:  J F SPRENT
Journal:  Parasitology       Date:  1958-05       Impact factor: 3.234

6.  Larva migrans.

Authors:  P C BEAVER
Journal:  Exp Parasitol       Date:  1956-11       Impact factor: 2.011

7.  FEATURES OF OCULAR INFESTATION BY TOXOCARA.

Authors:  I M Duguid
Journal:  Br J Ophthalmol       Date:  1961-12       Impact factor: 4.638

8.  CHRONIC ENDOPHTHALMITIS DUE TO TOXOCARA.

Authors:  I M Duguid
Journal:  Br J Ophthalmol       Date:  1961-11       Impact factor: 4.638

9.  Infection with animal helminths as a factor in causing poliomyelitis and epilepsy.

Authors:  A W Woodruff; B Bisseru; J C Bowe
Journal:  Br Med J       Date:  1966-06-25

10.  Gastrointestinal absorption and secretion of thiabendazole in ruminants.

Authors:  E C McManus; F V Washko; D J Tocco
Journal:  Am J Vet Res       Date:  1966-07       Impact factor: 1.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.